Log in to save to my catalogue

Aberrant PSA glycosylation—a sweet predictor of prostate cancer

Aberrant PSA glycosylation—a sweet predictor of prostate cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1286945710

Aberrant PSA glycosylation—a sweet predictor of prostate cancer

About this item

Full title

Aberrant PSA glycosylation—a sweet predictor of prostate cancer

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Urology, 2013-02, Vol.10 (2), p.99-107

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

In this Review, Gilgunn and colleagues consider how the specificity and sensitivity of the PSA assay has changed over the past 20 years and explain how the analysis of aberrant PSA glycosylation patterns could be used to investigate prostate cancer.
Prostate cancer—the most commonly diagnosed cancer in men worldwide—can have a substantial effect...

Alternative Titles

Full title

Aberrant PSA glycosylation—a sweet predictor of prostate cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1286945710

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1286945710

Other Identifiers

ISSN

1759-4812

E-ISSN

1759-4820

DOI

10.1038/nrurol.2012.258

How to access this item